Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microvascular involvement in cardiac pathology

J B Gavin1, L Maxwell, S G Edgar

  • 1Department of Pathology, University of Auckland, New Zealand.

Journal of Molecular and Cellular Cardiology
|February 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors.

Seminars in arthritis and rheumatism·2025
Same author

Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis.

Seminars in arthritis and rheumatism·2024
Same author

A Content Analysis of Personal Safety Apps: Are They Keeping Us Safe or Making Us More Vulnerable?

Violence against women·2019
Same author

B Cell Depletion With an Anti-CD20 Antibody Enhances Alloreactive Memory T Cell Responses After Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

The spatial and temporal distribution of insulin-like growth factor-1 following experimental myocardial infarction in the rat.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Prospective analysis of vitamin D and endometrial cancer risk.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Microvascular abnormalities play a key role in heart disease progression and outcomes. Understanding these changes in conditions like myocarditis and ischemic heart disease can help minimize heart muscle loss.

Area of Science:

  • Cardiovascular Research
  • Pathophysiology
  • Medical Science

Background:

  • Microvascular abnormalities are integral to the development and progression of various heart conditions.
  • These changes can be a primary cause or a consequence of heart disease, impacting conditions like viral myocarditis and Chagas' disease.
  • Focal microvascular issues are observed early in some cardiomyopathies and later in most myocarditis cases.

Purpose of the Study:

  • To elucidate the role of microvascular abnormalities in the pathogenesis and progression of heart diseases.
  • To understand the mechanisms behind microvascular dysfunction in conditions such as hypertension, myocarditis, and ischemic heart disease.
  • To identify potential therapeutic targets for minimizing myocyte loss by modulating angiogenesis and leukocyte activity.

Main Methods:

Related Experiment Videos

  • Review and synthesis of existing literature on microvascular changes in cardiac diseases.
  • Analysis of pathological mechanisms including arteriolar wall thickening, impaired angiogenesis, and microvascular stunning.
  • Examination of inflammatory responses and cellular events contributing to microvascular dysfunction.

Main Results:

  • Chronic hypertension leads to arteriolar wall thickening, impairing coronary hemodynamics and reducing coronary reserve.
  • Ischemic myocyte injury can result in the no-reflow phenomenon and reduced functional capillaries due to microvascular stunning.
  • Mechanisms of microvascular stunning include reperfusion injury, leukocyte activation, and impaired vasodilation.
  • Microvascular changes often represent a common inflammatory pathway in myocarditis, cardiomyopathy, and ischemic heart disease.

Conclusions:

  • Microvascular abnormalities are a critical factor in the pathophysiology of diverse heart diseases.
  • Interventions targeting angiogenesis and leukocyte activity hold promise for preserving cardiac function and minimizing myocyte loss.
  • Understanding these microvascular mechanisms is essential for developing effective treatments for heart failure and ischemic heart disease.